Animal Models and Experimental Medicine

metrics 2024

Advancing biomedical research through innovative animal models.

Introduction

Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.

Metrics 2024

SCIMAGO Journal Rank1.03
Journal Impact Factor3.80
Journal Impact Factor (5 years)3.50
H-Index25
Journal IF Without Self3.80
Eigen Factor0.00
Normal Eigen Factor0.31
Influence0.73
Immediacy Index0.60
Cited Half Life2.80
Citing Half Life5.80
JCI0.68
Total Documents317
WOS Total Citations858
SCIMAGO Total Citations1866
SCIMAGO SELF Citations86
Scopus Journal Rank1.03
Cites / Document (2 Years)3.91
Cites / Document (3 Years)4.13
Cites / Document (4 Years)3.76

Metrics History

Rank 2024

Scopus

Veterinary (miscellaneous) in Veterinary
Rank #4/35
Percentile 88.57
Quartile Q1
Medical Laboratory Technology in Health Professions
Rank #5/41
Percentile 87.80
Quartile Q1
Medicine (miscellaneous) in Medicine
Rank #80/398
Percentile 79.90
Quartile Q1
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #179/438
Percentile 59.13
Quartile Q2
Molecular Biology in Biochemistry, Genetics and Molecular Biology
Rank #198/410
Percentile 51.71
Quartile Q2

IF (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 112/313
Percentile 64.40
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 67/189
Percentile 64.80
Quartile Q2

JCI (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 150/313
Percentile 52.08
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 84/189
Percentile 55.56
Quartile Q2

Quartile History

Similar Journals

Experimental and Therapeutic Medicine

Unveiling the future of healthcare through innovative research.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Elevating healthcare through transformative research insights.
Publisher: TOHOKU UNIV MEDICAL PRESSISSN: 0040-8727Frequency: 12 issues/year

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

LAB ANIMAL

Exploring innovative solutions for animal welfare and research.
Publisher: NATURE PORTFOLIOISSN: 0093-7355Frequency: 11 issues/year

LAB ANIMAL, a journal published by NATURE PORTFOLIO, is a prominent source of knowledge in the fields of animal science and veterinary medicine. With its ISSN 0093-7355 and E-ISSN 1548-4475, it serves as a critical platform for researchers, professionals, and students dedicated to the advancement of laboratory animal science. Despite being categorized in the Q4 quartile for Animal Science and Zoology and Q3 for Veterinary (Miscellaneous) in 2023, its contributions are invaluable, reflecting rigorous research and development essential for improving laboratory animal care and ethical research practices. The journal aims to foster innovation and responsive dialogue in an evolving landscape of animal research, promoting a more humane and scientifically sound approach. Although it currently operates under a subscription-based model, LAB ANIMAL continues to be an essential resource for the academic community, providing insights that are integral to advancing both veterinary and animal sciences. The journal has consistently published research since its inception in 1995, engaging a diverse audience with comprehensive studies and discussions that impact the future of the field.

AMERICAN JOURNAL OF VETERINARY RESEARCH

Exploring the Frontiers of Veterinary Knowledge
Publisher: AMER VETERINARY MEDICAL ASSOCISSN: 0002-9645Frequency: 12 issues/year

American Journal of Veterinary Research, published by the American Veterinary Medical Association, serves as a cornerstone of the veterinary medical community, providing essential insights from 1945 to the present. With an ISSN of 0002-9645 and E-ISSN of 1943-5681, this esteemed journal focuses on a diverse range of topics within the veterinary field, contributing to the advancement of veterinary science through rigorous peer-reviewed research. Ranking in the Q2 category in Veterinary (miscellaneous) and Q3 in Medicine (miscellaneous) category as of 2023, it holds a respectable position in Scopus rankings, further emphasizing its impact in the field. While currently not an Open Access journal, its objective remains clear: to disseminate cutting-edge research that informs clinical practice and enhances animal health and welfare. The American Journal of Veterinary Research is invaluable for researchers, professionals, and students seeking to stay at the forefront of veterinary advancements and innovations.

Current Reviews in Clinical and Experimental Pharmacology

Unlocking the Future of Therapeutics Through Open Access
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 2772-4328Frequency: 4 issues/year

Current Reviews in Clinical and Experimental Pharmacology is a cutting-edge journal published by Bentham Science Publishers in the United Arab Emirates, focusing on the dynamic field of pharmacology. With an ISSN of 2772-4328 and an E-ISSN of 2772-4336, this journal has rapidly established itself as a significant resource for researchers and professionals in the medical and pharmaceutical sciences since its inception in 2021. It boasts an impressive Q3 ranking in Pharmacology (medical) and Q2 in the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) category as of 2023. Furthermore, it ranks #14/80 in general pharmacology, reflecting its esteemed position within the scientific community. As an Open Access publication, it ensures that groundbreaking research is readily accessible, fostering collaboration and innovation. The journal invites high-quality reviews and original articles that address contemporary issues and advancements in clinical and experimental pharmacology, making it an essential venue for disseminating knowledge and engaging with emerging trends in therapeutic developments.

Biomolecules and Biomedicine

Innovating Insights in Biomedical Research
Publisher: ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVOISSN: 2831-0896Frequency: 6 issues/year

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

Intensive Care Medicine Experimental

Elevating Patient Outcomes through Collaborative Research
Publisher: SPRINGERISSN: 2197-425XFrequency: 1 issue/year

Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

EXPERIMENTAL AND MOLECULAR MEDICINE

Connecting scholars to the latest in experimental medicine.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Empowering Researchers with Quality Pharmacological Knowledge
Publisher: WILEYISSN: 0305-1870Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Fostering excellence in physiological and pharmacological studies.
Publisher: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGYISSN: 1226-4512Frequency: 6 issues/year

Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.